Induction of autophagy-dependent apoptosis by the survivin suppressant YM155 in prostate cancer cells

Cancer Letters

Volumn 302, Issue 1, 2011, Pages 29-36

  Wang, Qinwen ^a   Chen, Zhengtang ^a   Diao, Xinwei ^a   Huang, Shengbing ^b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b MAYO CLINIC CANCER CENTER   (United States)

Author keywords

Apoptosis; Autophagy; Survivin; YM155

Indexed keywords

1 (2 METHOXYETHOXY) 2 METHYL 3 (2 PYRAZINYLMETHYL)NAPHTHO[2,3 D]IMIDAZOLE 4,9 DIONE; CELL PROTEIN; CHLOROQUINE; IMIDAZOLE DERIVATIVE; PROTEIN LC3I; PROTEIN LC3II; SMALL INTERFERING RNA; SURVIVIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER CELL; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN METABOLISM;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; BLOTTING, WESTERN; CELL LINE, TUMOR; CHLOROQUINE; FLOW CYTOMETRY; GREEN FLUORESCENT PROTEINS; HUMANS; IMIDAZOLES; LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEINS; MALE; MEMBRANE PROTEINS; MICROSCOPY, CONFOCAL; MICROTUBULE-ASSOCIATED PROTEINS; NAPHTHOQUINONES; PROSTATIC NEOPLASMS; RNA INTERFERENCE;

EID: 79251593832     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2010.12.007     Document Type: Article

References (39)

1. Jemal A., et al. Cancer statistics. CA Cancer J. Clin. 2010, 60(5):277-300.
2. Klein E.A., Kupelian P.A. Localized prostate cancer: radiation or surgery?. Urol. Clin. North Am. 2003, 30(2):315-330. ix.
3. Gozuacik D., Kimchi A. Autophagy and cell death. Curr. Top. Dev. Biol. 2007, 78:217-245.
4. Huang S., Sinicrope F.A. Celecoxib-induced apoptosis is enhanced by ABT-737 and by inhibition of autophagy in human colorectal cancer cells. Autophagy 2010, 6(2):2562-2569.
5. Amaravadi R.K., Thompson C.B. The roles of therapy-induced autophagy and necrosis in cancer treatment. Clin. Cancer Res. 2007, 13(24):7271-7279.
6. Levine B., Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008, 132(1):27-42.
7. Maiuri M.C., et al. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat. Rev. Mol. Cell Biol. 2007, 8(9):741-752.
8. Kabeya Y., et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. Embo J. 2000, 19(21):5720-5728.
9. Klionsky D.J., et al. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 2008, 4(2):151-175.
10. Kihara A., et al. Beclin-phosphatidylinositol 3-kinase complex functions at the trans-Golgi network. EMBO Rep. 2001, 2(4):330-335.
11. Pattingre S., et al. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 2005, 122(6):927-939.
12. Gonzalez-Polo R.A., et al. The apoptosis/autophagy paradox: autophagic vacuolization before apoptotic death. J. Cell Sci. 2005, 118(Pt 14):3091-3102.
13. Solomon V.R., Lee H. Chloroquine and its analogs: a new promise of an old drug for effective and safe cancer therapies. Eur. J. Pharmacol. 2009, 625(1-3):220-233.
14. Brown J.M., Attardi L.D. The role of apoptosis in cancer development and treatment response. Nat. Rev. Cancer 2005, 5(3):231-237.
15. Deveraux Q.L., Reed J.C. IAP family proteins - suppressors of apoptosis. Genes Dev. 1999, 13(3):239-252.
16. Schimmer A.D. Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice. Cancer Res. 2004, 64(20):7183-7190.
17. Altieri D.C., Marchisio P.C. Survivin apoptosis: an interloper between cell death and cell proliferation in cancer. Lab. Invest. 1999, 79(11):1327-1333.
18. Altieri D.C. Survivin in apoptosis control and cell cycle regulation in cancer. Prog. Cell Cycle Res. 2003, 5:447-452.
19. Altieri D.C. Survivin and apoptosis control. Adv. Cancer Res. 2003, 88:31-52.
20. Kanwar R.K., et al. Recent advances in anti-survivin treatments for cancer. Curr. Med. Chem. 2010, 17(15):1509-1515.
21. Shariat S.F., et al. Survivin expression is associated with features of biologically aggressive prostate carcinoma. Cancer 2004, 100(4):751-757.
22. Zhang M., et al. Survivin is a potential mediator of prostate cancer metastasis. Int. J. Radiat. Oncol. Biol. Phys. 2010, 78(4):1095-1103.
23. Nakahara T., et al. YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts. Cancer Res. 2007, 67(17):8014-8021.
24. De Schepper S., et al. Inhibition of histone deacetylases by chlamydocin induces apoptosis and proteasome-mediated degradation of survivin. J. Pharmacol. Exp. Ther. 2003, 304(2):881-888.
25. Sah N.K., et al. Effect of downregulation of survivin expression on radiosensitivity of human epidermoid carcinoma cells. Int. J. Radiat. Oncol. Biol. Phys. 2006, 66(3):852-859.
26. Wall N.R., et al. Suppression of survivin phosphorylation on Thr34 by flavopiridol enhances tumor cell apoptosis. Cancer Res. 2003, 63(1):230-235.
27. Giaccone G., et al. Multicenter phase II trial of YM155, a small-molecule suppressor of survivin, in patients with advanced, refractory, non-small-cell lung cancer. J. Clin. Oncol. 2009, 27(27):4481-4486.
28. Satoh T., et al. Phase I study of YM155, a novel survivin suppressant, in patients with advanced solid tumors. Clin. Cancer Res. 2009, 15(11):3872-3880.
29. Tolcher A.W., et al. Phase I and pharmacokinetic study of YM155, a small-molecule inhibitor of survivin. J. Clin. Oncol. 2008, 26(32):5198-5203.
30. Huang S., Okumura K., Sinicrope F.A. BH3 mimetic obatoclax enhances TRAIL-mediated apoptosis in human pancreatic cancer cells. Clin. Cancer Res. 2009, 15(1):150-159.
31. Okumura K., Huang S., Sinicrope F.A. Induction of Noxa sensitizes human colorectal cancer cells expressing Mcl-1 to the small-molecule Bcl-2/Bcl-xL inhibitor, ABT-737. Clin. Cancer Res. 2008, 14(24):8132-8142.
32. Pei H., et al. FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt. Cancer Cell 2009, 16(3):259-266.
33. Huang S., Sinicrope F.A. Sorafenib inhibits STAT3 activation to enhance TRAIL-mediated apoptosis in human pancreatic cancer cells. Mol. Cancer Ther. 2010, 9(3):742-750.
34. de Bruin E.C., Medema J.P. Apoptosis and non-apoptotic deaths in cancer development and treatment response. Cancer Treat. Rev. 2008, 34(8):737-749.
35. Klionsky D.J., Cuervo A.M., Seglen P.O. Methods for monitoring autophagy from yeast to human. Autophagy 2007, 3(3):181-206.
36. Fimia G.M., Piacentini M. Regulation of autophagy in mammals and its interplay with apoptosis. Cell. Mol. Life Sci. 2010, 67(10):1581-1588.
37. Boya P., Kroemer G. Beclin 1: a BH3-only protein that fails to induce apoptosis. Oncogene 2009, 28(21):2125-2127.
38. Erlich S., et al. Differential interactions between Beclin 1 and Bcl-2 family members. Autophagy 2007, 3(6):561-568.
39. Niu T.K., et al. Interaction of Beclin 1 with survivin regulates sensitivity of human glioma cells to TRAIL-induced apoptosis. FEBS Lett. 2010, 584(16):3519-3524.